Menopause Documentation Remains Inconsistent in EHRs

Scoping Review Finds Gaps in Menopause Data in EHRs

A new scoping review published in Menopause reports that menopause status and symptoms are inconsistently documented in electronic health record (EHR) systems. The review examined how menopause is identified and represented in EHR-based studies and summarized current documentation practices and limitations.

The study found that menopause-related information is often incomplete, inconsistently coded, or located in unstructured clinical notes, making it difficult to track symptoms and reproductive stage over time. This fragmentation limits care coordination and the ability to use EHR data for research.

Evidence and Study Scope

The evidence comes from a scoping review published in 2026 in the journal Menopause. The review synthesized findings from EHR-based studies on menopause documentation, focusing on how menopause status and symptoms are recorded and used in clinical and research settings.

The review applies to women in midlife and postmenopausal stages, a group that includes approximately 1.3 million U.S. women entering menopause each year and an estimated 1.1 billion women globally classified as postmenopausal.

Why Documentation Matters for Metabolic Health

Accurate documentation of menopause status and symptoms in EHRs is important for managing metabolic and other health risks associated with menopause. Menopause is linked to changes in cardiovascular, musculoskeletal, neurologic, and mental health, all of which can impact metabolic health.

When menopause status is inferred from proxy indicators like age or medication use, rather than structured documentation, clinicians may miss opportunities for early intervention or tailored care. Consistent data can also help patients and providers track symptom changes and responses to treatment over time.

Current Limitations and Opportunities for Improvement

The review found that validated symptom-assessment tools for menopause exist but are not routinely used in structured EHR workflows or mapped to standardized clinical terminology. As a result, menopause data may be fragmented across providers and institutions.

The authors suggest that developing standardized menopause data elements and incorporating validated screening tools into EHRs could improve clinical care, research comparability, and patient education. Achieving this will require coordinated, multidisciplinary efforts.

Caveats and Next Steps

The review highlights that current EHR systems often lack structured, standardized fields for menopause status and symptoms. This limits the ability to track health outcomes and compare treatments across populations.

The authors note that broader standardization and implementation of validated screening tools could help address these documentation gaps, but such changes will require systemic updates to EHR workflows and clinical practice.